Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer
Prostate cancer is the most common type of cancer and the leading cause of cancer deaths among men in many countries. Preventing progression is a major concern for prostate cancer patients on active surveillance, patients with recurrence after radical therapies, and patients who acquired resistance...
Main Authors: | Takuji Hayashi, Kazutoshi Fujita, Makoto Matsushita, Norio Nonomura |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/8/1153 |
Similar Items
-
Application of Anti-Inflammatory Agents in Prostate Cancer
by: Koji Hatano, et al.
Published: (2020-08-01) -
Current Perspectives on Pharmacological and Non-Pharmacological Interventions for the Inflammatory Mechanism of Unipolar Depression
by: Ioana-Alexandra Dogaru, et al.
Published: (2022-10-01) -
Immune response to influenza vaccination in the elderly is altered by chronic medication use
by: Divyansh Agarwal, et al.
Published: (2018-08-01) -
Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention
by: Mark A Moyad, et al.
Published: (2015-01-01) -
Statin and metformin therapy in prostate cancer patients with hyperlipidemia who underwent radiotherapy: a population-based cohort study
by: Li K, et al.
Published: (2019-02-01)